Stay updated on Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    - The page now shows Revision: v3.5.3, replacing the earlier Revision: v3.5.2. This is a minor page/document revision update and does not modify study data or functionality.
    Difference
    0.0%
    Check dated 2026-04-30T16:27:48.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.0 to v3.5.2 on the page.
    Difference
    0.0%
    Check dated 2026-04-16T09:57:06.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Revision notes updated: added 'Revision: v3.5.0' and removed 'Revision: v3.4.3'.
    Difference
    0.0%
    Check dated 2026-03-25T20:13:27.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Revision tag updated to v3.4.3 (replacing the previous v3.4.2).
    Difference
    0.0%
    Check dated 2026-03-11T14:05:12.000Z thumbnail image
  7. Check
    88 days ago
    Change Detected
    Summary
    Added Primary peritoneal carcinoma to the study conditions and a Resources link for the Genetic and Rare Diseases Information Center. Updated page revision to v3.4.2 and removed the government funding lapse notice along with the previous revision note v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-11T02:48:41.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Added a system notice about a lapse in government funding and updated page revision from v3.4.0 to v3.4.1, with no changes to trial content or core functionality; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-04T00:27:43.000Z thumbnail image

Stay in the know with updates to Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Ovarian Cancer Clinical Trial page.